|
| 36594832 | Dynamic release of neuronal extracellular vesicles containing miR-21a-5p is induced by hypoxia. | J Extracell Vesicles | 2023 |
| 37945903 | Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. | Nat Genet | 2023 |
| 36983083 | A Compendium of AR Splice Variants in Metastatic Castration-Resistant Prostate Cancer. | Int J Mol Sci | 2023 |
| 37408211 | Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids. | Cells | 2023 |
| 37272338 | Site-specific analysis of ribosomal 2'O-methylation by quantitative reverse transcription PCR under low deoxynucleotide triphosphate concentrations. | Biotechniques | 2023 |
| 36549551 | Isolation-free measurement of single urinary extracellular vesicles by imaging flow cytometry. | Nanomedicine | 2023 |
| 36916183 | The quick reference card "Storage of urinary EVs" - A practical guideline tool for research and clinical laboratories. | J Extracell Vesicles | 2023 |
| 36874601 | Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting. | Eur Urol Open Sci | 2023 |
| 36865297 | Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients. | medRxiv | 2023 |
| 34608482 | The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis. | Neuro Oncol | 2022 |
| 35769712 | Cell Line Characteristics Predict Subsequent Resistance to Androgen Receptor-Targeted Agents (ARTA) in Preclinical Models of Prostate Cancer. | Front Oncol | 2022 |
| 35830458 | Identifying genes targeted by disease-associated non-coding SNPs with a protein knowledge graph. | PLoS One | 2022 |
| 35396392 | CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue. | Commun Biol | 2022 |
| 36429059 | Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling. | Cells | 2022 |
| 35037287 | Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling. | Prostate | 2022 |
| 33473200 | Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. | Nat Genet | 2021 |
| 33761899 | Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer. | BMC Cancer | 2021 |
| 33925994 | Gene Regulation Network Analysis on Human Prostate Orthografts Highlights a Potential Role for the <i>JMJD6</i> Regulon in Clinical Prostate Cancer. | Cancers (Basel) | 2021 |
| 33782168 | Comparing Approaches to Normalize, Quantify, and Characterize Urinary Extracellular Vesicles. | J Am Soc Nephrol | 2021 |
| 34891161 | Fusion transcripts and their genomic breakpoints in polyadenylated and ribosomal RNA-minus RNA sequencing data. | Gigascience | 2021 |
| 34675268 | Simple urine storage protocol for extracellular vesicle proteomics compatible with at-home self-sampling. | Sci Rep | 2021 |
| 34434533 | Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer. | J Extracell Vesicles | 2021 |
| 34724897 | FASTAFS: file system virtualisation of random access compressed FASTA files. | BMC Bioinformatics | 2021 |
| 34775914 | The role of OncoSnoRNAs and Ribosomal RNA 2'-O-methylation in Cancer. | RNA Biol | 2021 |
| 34035881 | Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles. | J Extracell Vesicles | 2021 |
| 33137405 | Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors. | Biochim Biophys Acta Rev Cancer | 2021 |
| 33398198 | Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. | Nat Genet | 2021 |
| 31401014 | Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting. | Eur Urol Oncol | 2020 |
| 32699318 | The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs. | Nat Rev Urol | 2020 |
| 31411736 | Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression. | Int J Cancer | 2020 |
| 30622367 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. | Nat Genet | 2019 |
| 31180178 | AR splice variants in circulating tumor cells of patients with castration-resistant prostate cancer: relation with outcome to cabazitaxel. | Mol Oncol | 2019 |
| 31018022 | Differential tissue expression of extracellular vesicle-derived proteins in prostate cancer. | Prostate | 2019 |
| 31017696 | A bypass mechanism of abiraterone-resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signaling. | Prostate | 2019 |
| 30735634 | Widespread and Functional RNA Circularization in Localized Prostate Cancer. | Cell | 2019 |
| 31055861 | Androgen receptor (AR) splice variant 7 and full-length AR expression is associated with clinical outcome: a translational study in patients with castrate-resistant prostate cancer. | BJU Int | 2019 |
| 30654439 | Extracellular Vesicle Quantification and Characterization: Common Methods and Emerging Approaches. | Bioengineering (Basel) | 2019 |
| 28801127 | Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680-7. | Eur Urol | 2018 |
| 29892050 | Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. | Nat Commun | 2018 |
| 29892016 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. | Nat Genet | 2018 |
| 30133757 | Tumor heterogeneity, aggressiveness, and immune cell composition in a novel syngeneic PSA-targeted Pten knockout mouse prostate cancer (MuCaP) model. | Prostate | 2018 |
| 29914715 | Fractionated Radiation of Primary Prostate Basal Cells Results in Downplay of Interferon Stem Cell and Cell Cycle Checkpoint Signatures. | Eur Urol | 2018 |
| 29968252 | Consensus molecular subtype classification of colorectal adenomas. | J Pathol | 2018 |
| 29921693 | Epithelial-Mesenchymal Transition in Human Prostate Cancer Demonstrates Enhanced Immune Evasion Marked by IDO1 Expression. | Cancer Res | 2018 |
| 29305224 | SNPitty: An Intuitive Web Application for Interactive B-Allele Frequency and Copy Number Visualization of Next-Generation Sequencing Data. | J Mol Diagn | 2018 |
| 29295717 | Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations. | BMC Cancer | 2018 |
| 27733296 | The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. | Eur Urol | 2017 |
| 28935391 | Extracellular vesicles released by mesenchymal-like prostate carcinoma cells modulate EMT state of recipient epithelial-like carcinoma cells through regulation of AR signaling. | Cancer Lett | 2017 |
| 28856701 | Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer. | Prostate | 2017 |
| 27907910 | A mononucleotide repeat in PRRT2 is an important, frequent target of mismatch repair deficiency in cancer. | Oncotarget | 2017 |